---

---

symbols : SNY    crawled time : 00:00   

save search

---

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
first drug authorized food depression treatment clearance for therapeutics

---

Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)
Published: 2024-04-16 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 1.11% | O: -1.75% H: 0.85% C: 0.85%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 1.23% | O: -2.13% H: 0.0% C: 0.0%
medical

---

Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 1.41% | O: 2.24% H: 0.0% C: -0.8%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 1.11% | O: 0.84% H: 0.0% C: 0.0%
preclinical meeting

---

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-31 (Crawled : 00:00) - globenewswire.com
CUBT | $0.0254 200K |

n/a

| 7.14% | O: 3.57% H: 0.0% C: -6.9%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -3.66% | O: -0.97% H: 0.0% C: 0.0%

---

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX
Published: 2024-03-26 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| -5.96% | O: -0.26% H: 0.0% C: 0.0%
TGAN | $4.82 -0.21% 39K |

Manufacturing

| -1.43% | O: 0.2% H: 0.0% C: -0.2%
FREE | $4.82 120K |

Consumer Non-Durables

| 0.0% | O: 0.0% H: 0.21% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -3.57% | O: 1.06% H: 0.0% C: 0.0%
INBX | $34.145 -0.68% 18K |

Health Technology

| -1.97% | O: 0.29% H: 0.23% C: -0.06%
HMST | $11.865 -3.3% 49K |

Finance

| -19.8% | O: 0.26% H: 0.07% C: -0.85%
EVBG | $34.9 0.03% 170K |

Technology Services

| 0.29% | O: 0.09% H: 0.03% C: -0.03%

---

Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published: 2024-03-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| -5.96% | O: -0.26% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K |

Health Technology

| -2.93% | O: 0.49% H: 0.84% C: -0.07%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -3.57% | O: 1.06% H: 0.0% C: 0.0%
INCY | $51.28 -0.89% 87K |

Health Technology

| -8.51% | O: -0.09% H: 1.42% C: 1.1%
ibi310 first cancer colon therapy study

---

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 0.3% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.3% | O: 0.42% H: 0.0% C: 0.0%
million

---

Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| -0.94% | O: -0.02% H: 0.0% C: 0.0%
BAX | $40.005 -2.26% 670K |

Health Technology

| -1.47% | O: 0.02% H: 1.03% C: 0.96%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.22% | O: -1.51% H: 0.0% C: 0.0%
GILD | $65.93 -1.71% 1.9M |

Health Technology

| -8.44% | O: 0.11% H: 0.59% C: 0.1%
BIIB | $198.365 -1.8% 310K |

Health Technology

| -7.94% | O: -0.48% H: 0.31% C: 0.13%
reach cancer treatment global market

---

Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD)
Published: 2024-03-19 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| -0.94% | O: -0.02% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.22% | O: -1.51% H: 0.0% C: 0.0%
ibi302 macular trial

---

Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends
Published: 2024-03-14 (Crawled : 00:00) - prnewswire.com
MS | News 0 d | $92.17 -1.79% 530K |

Finance

| 4.31% | O: -0.39% H: 0.45% C: 0.11%
ABT | News | $106.535 -0.33% 510K |

Health Technology

| -11.42% | O: -0.51% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.81% | O: 0.23% H: 0.0% C: 0.0%
NKTR | News | $1.355 -1.81% 68K |

Health Technology

| 62.35% | O: 2.35% H: 2.3% C: -1.15%
IMAB | $1.79 -1.11% 17K |

Health Technology

| -1.63% | O: -1.63% H: 0.55% C: -0.55%
report contract royalty trends deal

---

Global Immune Thrombocytopenia Drug Markets, 2019-2022 and 2023-2029: Advanced Drug Delivery Technologies Transform Management, Second-Generation TPO-RAs Revolutionize Treatment Options
Published: 2024-03-12 (Crawled : 00:00) - prnewswire.com
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.85% | O: -0.04% H: 0.0% C: 0.0%
drug treatment global advanced

---

Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
Published: 2024-03-12 (Crawled : 00:00) - prnewswire.com
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.84% | O: 0.01% H: 0.0% C: 0.0%
INCY | $51.28 -0.89% 87K |

Health Technology

| -14.89% | O: -0.12% H: 0.3% C: -2.29%
preclinical meeting

---

Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $135.35 400 |

Health Technology

| 4.72% | O: 3.21% H: 0.0% C: -1.71%
NVS | News | $98.67 0.33% 260K |

Health Technology

| -1.58% | O: 0.08% H: 0.86% C: 0.7%
JNJ | News | $147.46 -0.72% 820K |

Health Technology

| -7.43% | O: -0.68% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K |

Health Technology

| -3.58% | O: -0.02% H: 0.0% C: -2.29%
ABT | News | $106.535 -0.33% 510K |

Health Technology

| -11.0% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.36% | O: -0.08% H: 0.0% C: 0.0%
AZN | News | $75.19 5.6% 4.4M |

Health Technology

| 7.57% | O: -0.03% H: 0.62% C: 0.5%
AMGN | News | $268.16 -1.78% 290K |

Health Technology

| 0.05% | O: -0.02% H: 1.37% C: 0.34%
company report global market

---

Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
ABT | News | $106.535 -0.33% 510K |

Health Technology

| -9.74% | O: 1.41% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 0.23% | O: 1.62% H: 0.0% C: 0.0%
QDEL | News 4 | $39.35 -3.6% 71K |

Health Technology

| -4.78% | O: 1.14% H: 4.36% C: 3.16%
AMGN | News | $268.16 -1.78% 290K |

Health Technology

| -1.29% | O: -0.1% H: 0.18% C: -1.25%
cancer treatment growth market

---

Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia
Published: 2024-03-01 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| -0.95% | O: 0.01% H: 0.0% C: -0.43%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -1.14% | O: -1.27% H: 0.0% C: 0.0%
ibi3002 first australia study

---

Colorectal Cancer Therapeutics Market Set for Growth, New Report Analyzes 8MM Forecast to 2031: Focus on United States, France, Germany, Italy, Spain, United Kingdom, Japan, and China
Published: 2024-02-19 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 1.79% | O: 2.72% H: 0.0% C: -0.8%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 2.63% | O: 2.53% H: 0.0% C: 0.0%
report cancer set therapeutics china market

---

Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published: 2024-02-13 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 1.1% | O: -2.71% H: 0.0% C: 0.0%
NVS | News | $98.67 0.33% 260K |

Health Technology

| -0.72% | O: -0.02% H: 0.24% C: 0.01%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 2.76% | O: -1.1% H: 0.0% C: 0.0%
disease reach market

---

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| -5.48% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.0 -0.27% 0 |

Health Technology

| 1.1% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400 |

Health Technology

| 9.6% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $40.93 0.17% 170K |

Health Technology

| -1.28% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $724.615 -1.04% 480K |

Health Technology

| 1.24% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $395.72 -1.26% 130K |

Health Technology

| -3.67% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 2.76% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $198.365 -1.8% 310K |

Health Technology

| -10.88% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $75.19 5.6% 4.4M |

Health Technology

| 16.66% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $268.16 -1.78% 290K |

Health Technology

| -6.01% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 1.2K |

Health Technology

| -14.57% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400 |

Health Technology

| 1.13% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 52K |

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.79 3.4K |

Manufacturing

| 38.56% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.47 400K |

Manufacturing

| -13.04% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.115 -0.87% 260K |

Health Technology

| -6.57% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $98.67 0.33% 260K |

Health Technology

| -5.2% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.46 -0.72% 820K |

Health Technology

| -4.88% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K |

Health Technology

| 6.69% | O: 0.76% H: 4.31% C: 2.11%
BMY | $45.36 -7.16% 10M |

Health Technology

| -0.81% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $166.41 -0.83% 860K |

Health Technology

| -1.88% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $395.72 -1.26% 130K |

Health Technology

| -3.69% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| 1.97% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $107.68 -0.59% 28K |

Health Technology

| -13.14% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $75.19 5.6% 4.4M |

Health Technology

| 6.21% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $268.16 -1.78% 290K |

Health Technology

| -13.62% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

Global Hyaluronic Acid Raw Material Market Forecast Report 2024-2034, Featuring Zimmer Biomet, Sanof,i AbbVie, Anika Therapeutics, Lifecore Biomedical, Salix Pharmaceuticals & LG Chem
Published: 2024-02-01 (Crawled : 00:00) - prnewswire.com
LFCR | $6.18 -2.37% 13K |

Manufacturing

| -2.31% | O: 0.15% H: 1.86% C: 0.0%
ABBV | News | $166.41 -0.83% 860K |

Health Technology

| 2.56% | O: 3.59% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M |

Health Technology

| -2.09% | O: -0.93% H: 0.0% C: 0.0%
ANIK | $25.615 -1.1% 2.4K |

Health Technology

| 10.68% | O: -1.24% H: 2.86% C: -0.04%
report raw pharmaceuticals global market

---

Gainers vs Losers

46%

54%

Top 10 Gainers

SGBX | $0.26 80.43% 54M |

Producer Manufacturing

LICN | $1.0 78.57% 3.3M |

CSSE 4 | $0.2656 74.39% 9.7M |

Consumer Services

BRFH 4 | $1.89 71.82% 32M |

Manufacturing

ACON | $0.49 70.14% 24M |

n/a

BOF | $1.95 66.67% 920K |

MTC | $3.62 61.61% 790K |

Technology Services

AMST | $3.22 61.0% 720K |

Technology Services

PCSA | $2.28 40.74% 37M |

Producer Manufacturing

EVA | $0.626 39.14% 2.3M |

Process Industries

---

Your saved searches

---